×

Inhibiting of tumor growth with an antagonist of the renin-angioten-sin system

  • US 4,898,732 A
  • Filed: 05/04/1988
  • Issued: 02/06/1990
  • Est. Priority Date: 05/04/1988
  • Status: Expired due to Fees
First Claim
Patent Images

1. The method of implanting in a patient a controlled-release member, said member containing and releasing in controlled manner an effective dose a member selected from the group consisting of enalapril maleate, catapril and seralasin acetate, of a pharmaceutical antagonist of the renin-angiotensin system of said patient, whereby the growth of vascularization in said patient at least in an area adjacent said implanted controlled-release member is inhibited.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×